Theodore James Jr. Washburn - 01 Feb 2023 Form 4 Insider Report for AGIOS PHARMACEUTICALS, INC. (AGIO)

Role: Principal Accounting Officer
Signature: /s/ William Cook, as attorney-in-fact for Theodore James Jr. Washburn
Issuer symbol: AGIO
Transactions as of: 01 Feb 2023
Net transactions value: -$7,764
Form type: 4
Filing time: 14 Feb 2023, 15:06:35 UTC
Previous filing: 03 Mar 2022
Next filing: 16 Feb 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	AGIO	Common stock	Options Exercise	$0	+777	+29%	$0.000000	3,445	10 Feb 2023	Direct	F1
transaction	AGIO	Common stock	Tax liability	$7,764	-273	-7.9%	$28.44	3,172	14 Feb 2023	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	AGIO	Restricted stock units	Award	$0	+6,896		$0.000000	6,896	01 Feb 2023	Common stock	6,896		Direct	F2, F3
transaction	AGIO	Restricted stock units	Options Exercise	$0	-777	-50%	$0.000000	777	10 Feb 2023	Common stock	777		Direct	F2, F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Includes 119 shares purchased through the Company's employee stock purchase plan.
F2	Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.
F3	The restricted stock units were granted on February 1, 2023. The shares underlying the restricted stock units will vest in full on February 1, 2025.
F4	The restricted stock units were granted on February 10, 2021. Beginning on February 10, 2022, the shares underlying the restricted stock units will vest in three equal annual installments.